文献速递主动脉疾病外周动脉疾病

布鲁菌所致感染性主动脉-髂动脉瘤的腔内覆膜支架修复

Endovascular Stent Graft Repair for Mycotic Aorto-Iliac Aneurysm Due to Brucella.
PubMed 文献 · J Endovasc Ther · 2023-02-18

本研究回顾性分析2012年1月至2021年12月2家医院收治的15例布鲁菌主动脉-髂动脉瘤患者,均行腔内动脉瘤修复(EVAR)并联合多西环素与利福平抗生素治疗至术后6个月。即刻技术成功率100%,无术后死亡,中位随访45个月全部存活,支架均通畅且无内漏。作者认为EVAR联合抗生素治疗可行、安全、有效,是此类布鲁菌动脉瘤有前景的治疗选择。

要点

  • 15例布鲁菌主动脉-髂动脉瘤患者均行EVAR,无中转开放手术,即刻技术成功率100%
  • 6例因动脉瘤破裂行急诊手术,术后无死亡
  • 中位随访45个月全部存活,CT血管造影示支架均通畅、无内漏

核心结论

  • EVAR联合抗生素治疗对布鲁菌动脉瘤可行、安全、有效,是此类布鲁菌动脉瘤有前景的治疗选择。

研究设计与样本

  • 回顾性收集并分析2012年1月至2021年12月2家医院接受腔内修复的15例布鲁菌主动脉-髂动脉瘤患者的临床资料。

主要发现

  • 15例患者中男12例、女3例,平均年龄59.3岁;14例(93.3%)有牛、羊等动物接触史。
  • 全部患者均为主动脉或髂动脉假性动脉瘤,其中腹主动脉瘤9例、髂动脉瘤4例、腹主动脉瘤合并髂动脉瘤2例。
  • 全部患者行EVAR,无中转开放手术;6例因动脉瘤破裂行急诊手术;即刻技术成功率100%,无术后死亡。
  • 2例术后因缺乏抗生素治疗再次发生髂动脉破裂,再次接受腔内治疗。
  • 中位随访45个月全部存活,随访CT血管造影示所有支架均通畅、无内漏。

关键数值与推荐

  • 确诊布鲁菌病后,全部患者启动多西环素与利福平抗生素治疗,持续至术后6个月。
  • 即刻技术成功率100%,无术后死亡,中位随访45个月生存率100%。
  • 传统开放手术切除并清创感染动脉瘤及周围组织的死亡率为13.3%-40%。

临床怎么用

  • 作者认为EVAR联合抗生素治疗对布鲁菌动脉瘤可行、安全、有效,是部分感染性动脉瘤有前景的治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Brucella aneurysms are very rare but life-threatening, and a standard treatment approach has yet to be established. The current study aimed to assess the safety and efficacy of endovascular treatment for Brucella aneurysms. MATERIALS AND METHODS: The clinical data of 15 Brucella aortic-iliac aneurysm patients who underwent endovascular repair at 2 hospitals from January 2012 to December 2021 were retrospectively collected and analyzed. RESULTS: Fifteen patients (12 men and 3 women) with a mean age of 59.3 years were included. Fourteen patients (93.3%) had a history of exposure to animals (cattle and sheep). All patients had aortic or iliac pseudoaneurysms, 9 abdominal aortic aneurysms (AAAs), 4 iliac aneurysms, and 2 AAA combined with iliac aneurysms. Endovascular aneurysm repair (EVAR) was performed in all patients without conversion to open surgery. Six cases were treated for emergency surgery due to aneurysm rupture. The immediate technique success rate was 100%, with no postoperative death. Two cases had the iliac artery ruptured again after operation because of lack of antibiotic treatment and was given endovascular treatment again. Once brucellosis is diagnosed, antibiotic treatment with doxycycline and rifampicin was initiated for all the patients until 6 months after operation. All patients survived over a median follow-up period of 45 months. Follow-up computed tomography angiography showed that all stent grafts remained patent, with no endoleak. CONCLUSION: EVAR combined with antibiotics treatment is feasible, safe, and effective for Brucella aneurysms and represents a promising treatment option for these Brucella aneurysms. CLINICAL IMPACT: Brucella aneurysms are very rare but life-threatening, and a standard treatment approach has yet to be established. The traditional operation management strategy is surgical resection and debridement of the infected aneurysm and the surrounding tissues. However, open surgical management in these patients causes severe trauma with high surgical risks and mortality (13.3%-40%). We tried to treat Brucella aneurysms with endovascular therapy, and the technique success and survival rate of the operation reached 100%. EVAR combined with antibiotics treatment is feasible, safe, and effective for Brucella aneurysms and represents a promising treatment option for some mycotic aneurysms.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Jiang J, Shao W, Shen S, et al. Endovascular Stent Graft Repair for Mycotic Aorto-Iliac Aneurysm Due to Brucella. J Endovasc Ther. 2023. PMID: 36802851. doi:10.1177/15266028231155139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。